MedTrace Logo

Evaluation of Potential Off-label Use of Dabigatran Etexilate in Europe

NCT02240654 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36573

Last updated 2017-12-15

Study results available
· View outcomes & findings →

Summary

This is a descriptive, observational, multi-country European cross-sectional study of new users of dabigatran etexilate that aims to characterise on- and off-label status and other medical characteristics at the time of the first captured prescription of dabigatran etexilate in each database. The study will be conducted using Cegedim Strategic Database (CSD, France), Danish National Databases (Denmark) and Clinical Practice Research Datalink (CPRD, UK).

Conditions

Sponsors & Collaborators

Principal Investigators

  • Boehringer Ingelheim · Boehringer Ingelheim

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-28
Primary Completion
2016-05-20
Completion
2016-05-20

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02240654 on ClinicalTrials.gov